Position in ZTS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,528,102
-$76,598 QoQ
Shares Held
21,265
+56.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#547
of 1,412 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cascade Investment Advisors, Inc. holds $1,528,102 across 1 Drug Manufacturers - Specialty & Generic name. ZTS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
21,265 | $1,528,102 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,528,102 | 21,265 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,604,700 | 13,575 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,499,145 | 11,915 | Shares | Sole | 2026-01-14 | |
| 2023-03-31 | $5,825 | 35 | Shares | Sole | 2023-05-10 | |
| 2022-06-30 | $6,016 | 35 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,600 | 35 | Shares | Sole | 2022-04-11 | |
| No filing history on record for this holder in this stock. | ||||||